BI1479-0001

Clinical Trial Grant

Duke Scholars

Principal Investigator Thomas Eldridge Stinchcombe Medicine, Medical Oncology

Administered By

Duke Cancer Institute

Awarded By

Boehringer Ingelheim Pharmaceuticals, Inc.

Start Date

September 6, 2023

End Date

August 31, 2028

Administered By

Duke Cancer Institute

Awarded By

Boehringer Ingelheim Pharmaceuticals, Inc.

Start Date

September 6, 2023

End Date

August 31, 2028